Table 3 Adjusted hazard ratio of determine factors associated with prognosis of patients in multivariate model for patients with T2-T3 esophageal cancer.

From: Survival benefit of surgery to patients with esophageal squamous cell carcinoma

Variable

HR*

95% CI

P value

Age

 <65

Ref

  

 ≥65

1.23

1.01–1.50

0.037

Gender

 Female

Ref

  

 Male

1.64

1.10–2.44

0.016

Clinical T stage

 T2

Ref

  

 T3

1.57

1.23–1.99

<0.001

Clinical N stage

 N0

Ref

  

 N(+)

1.30

0.98–1.71

0.065

Treatment

 Definite CCRT

Ref

  

 Surgery+/−Neo/adjuvant Tx

0.48

0.39–0.59

<0.001

 Palliative treatment

1.34

1.08–1.67

0.008

  1. *HRs were estimated for multivariable Cox model with the variables listed in the table.
Back to article page